Epidemiology of medication overuse headache in the general Swedish population

Cephalalgia

Volumn 31, Issue 9, 2011, Pages 1015-1022

  Jonsson, Pernilla ^a   Hedenrud, Tove ^a   Linde, Mattias ^a,b,c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Chronic daily headache; epidemiology; medication overuse headache; prevalence; socioeconomic status

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; CAFFEINE; ERGOTAMINE DERIVATIVE; IBUPROFEN; OPIATE DERIVATIVE; PARACETAMOL; TRIPTAN DERIVATIVE;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC DAILY HEADACHE; DISEASE ASSOCIATION; DRUG INDUCED HEADACHE; FEMALE; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MIGRAINE; ONSET AGE; PREVALENCE; PRIMARY HEADACHE; SWEDEN; TENSION HEADACHE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANALGESICS; FEMALE; HEADACHE DISORDERS, SECONDARY; HUMANS; MALE; MIDDLE AGED; PREVALENCE; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; SWEDEN; YOUNG ADULT;

EID: 80051969471     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102411410082     Document Type: Article

References (27)

1. Jensen R, Bendtsen L. Medication overuse headache in Scandinavia. Cephalalgia. 2008 ; 28: 1237-1239
2. Aaseth K, Grande RB, Kvaerner KJ, Gulbrandsen P, Lundqvist C, Russell MB. Prevalence of secondary chronic headaches in a population-based sample of 30-44-year-old persons. The Akershus study of chronic headache. Cephalalgia. 2008 ; 28: 705-713 (Pubitemid 351799748)
3. Colas R, Munoz P, Temprano R, Gomez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology. 2004 ; 62: 1338-1342 (Pubitemid 38526046)
4. Katsarava Z, Dzagnidze A, Kukava M. Primary headache disorders in the Republic of Georgia: prevalence and risk factors. Neurology. 2009 ; 73: 1796-1803
5. Straube A, Pfaffenrath V, Ladwig KH, Meisinger C, Hoffmann W, Fendrich K, et al. Prevalence of chronic migraine and medication overuse headache in Germany-the German DMKG headache study. Cephalalgia. 2009 ; 30: 207-213
6. Diener H, Dahlöf CGH The headaches. 2 nd edn Olesen J Tfelt-Hansen P Welch KMA, ed. Philadelphia: Lippincott Williams & Wilkins ; 1999: 871-878.
7. D'Amico D, Grazzi L, Usai S, Rigamonti A, Curone M, Bussone G. Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura. Headache. 2005 ; 45: 553-560 (Pubitemid 40847180)
8. Atasoy HT, Unal AE, Atasoy N, Emre U, Sumer M. Low income and education levels may cause medication overuse and chronicity in migraine patients. Headache. 2005 ; 45: 25-31 (Pubitemid 40096176)
9. Hagen K, Vatten L, Stovner LJ, Zwart JA, Krokstad S, Bovim G. Low socio-economic status is associated with increased risk of frequent headache: a prospective study of 22718 adults in Norway. Cephalalgia. 2002 ; 22: 672-679 (Pubitemid 36609337)
10. Kavuk I, Weimar C, Kim BT, Gueneyli G, Araz M, Klieser E, et al. One-year prevalence and socio-cultural aspects of chronic headache in Turkish immigrants and German natives. Cephalalgia. 2006 ; 26: 1177-1181 (Pubitemid 44359336)
11. Laurell K, Larsson B, Eeg-Olofsson O. Prevalence of headache in Swedish schoolchildren, with a focus on tension-type headache. Cephalalgia. 2004 ; 24: 380-388 (Pubitemid 38621817)
12. Apotekensservice. Report of OTC sale. http://www.apotekensservice.se/ Nyheter-och-Press/Presskontakt/Pressmeddelanden/Forsaljningen-av-receptfria- lakemedel-okar-bade-i-dagligvaruhandeln-och-pa-apotek/ (Accessed 1 October 2010.).
13. Tfelt-Hansen P, Steiner TJ. Over-the-counter triptans for migraine: what are the implications?. CNS Drugs. 2007 ; 21: 877-883 (Pubitemid 47557103)
14. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 ; 26: 742-746
15. Committee IHSHC. The international Classification of headache disorders, 2nd edition. Cephalalgia. 2004 ; 24: 1-160
16. Hosmer DW, Lemeshow S Applied logistic regression. 2 nd edn New York, Chichester: Wiley ; 2000 :
17. Linde M, Stovner LJ, Zwart JA, Hagen K. Time trends in the prevalence of headache disorders. The Nord-Trondelag Health Studies (HUNT 2 and HUNT 3). Cephalalgia. 2011 ; 5: 585-596
18. Stovner LJ, Andree C. Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain. 2010 ; 11: 289-299
19. Castillo J, Munoz P, Guitera V, Pascual J. Epidemiology of chronic daily headache in the general population. Headache. 1999 ; 39: 190-196 (Pubitemid 29190083)
20. Lu SR, Fuh JL, Chen WT, Juang KD, Wang SJ. Chronic daily headache in Taipei, Taiwan: prevalence, follow-up and outcome predictors. Cephalalgia. 2001 ; 21: 980-986
21. Wiendels NJ, Knuistingh Neven A, Rosendaal FR, Spinhoven P, Zitman FG, Assendelft WJ, et al. Chronic frequent headache in the general population: prevalence and associated factors. Cephalalgia. 2006 ; 26: 1434-1442
22. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol. 2004 ; 3: 475-483 (Pubitemid 38903098)
23. Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology. 2006 ; 66: 1894-1898 (Pubitemid 44049823)
24. Programme UND. Human Development Report: Economy and inequality, Gini index. http://hdrstats.undp.org/en/indicators/161.html (Accessed 1 October 2010).
25. Statistics Sweden S. Census data. http://www.scb.se/Pages/Product-25799. aspx (Accessed 1 October 2010).
26. Sheffield RE. Migraine prevalence: a literature review. Headache. 1998 ; 38: 595-601 (Pubitemid 28481002)
27. Hagen K, Zwart JA, Aamodt AH, Nilsen KB, Brathen G, Helde G, et al. The validity of questionnaire-based diagnoses: the third Nord-Trondelag Health Study 2006-2008. J Headache Pain. 2010 ; 11: 67-73